comparemela.com

Latest Breaking News On - Sanofi incyte - Page 1 : comparemela.com

Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib（ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting

SAN FRANCISCO, U.S. and SUZHOU, China, June 2, 2024 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company…

China
Tongji
Sichuan
Suzhou
Jiangsu
Rhui-zhou
Guangdong
United-states
Hong-kong
Shanghai
Taiwan
Macau

Innovent Announces Data From Pivotal Phase 2 TRUST-I Study Of Taletrectinib(ROS1 Inhibitor) Are Published In The JCO And Reported At 2024 ASCO Annual ...

SAN FRANCISCO, U.S. and SUZHOU, China, June 1, 2024 /PRNewswire/ Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceut

Rhui-zhou
Guangdong
China
Tongji
Sichuan
Suzhou
Jiangsu
Shanghai
Hong-kong
Taiwan
Macau
United-states

Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other Solid Tumors at the 2024 ASCO Annual Meeting

/PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes.

China
Yu-chen
Zhejiang
Suzhou
Jiangsu
Fujian
Rhui-zhou
Guangdong
Australia
United-states
Innovent-biologics
Tingbo-liang

Innovent Presents at the 2024 ASCO Annual Meeting on Clinical Data of anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Pancreatic Cancer or Biliary Tract Cancer

/PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes.

China
Australia
Rhui-zhou
Guangdong
United-states
Suzhou
Jiangsu
American
Innovent-biologics
Hana-claudin
Eli-lilly
Xianjun-yu

Innovent Receives NMPA Breakthrough Therapy Designation for IBI343（Anti-Claudin18.2 ADC）as Monotherapy for Advanced Gastric Cancer

SAN FRANCISCO and SUZHOU, China, May 7, 2024 /PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that

United-states
Rhui-zhou
Guangdong
China
Thailand
Macau
Taiwan
Japan
Hong-kong
Suzhou
Jiangsu
Sanofi-incyte

vimarsana © 2020. All Rights Reserved.